Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1315) 1315
science & technology (1101) 1101
life sciences & biomedicine (1082) 1082
osteonecrosis - chemically induced (908) 908
diphosphonates - adverse effects (843) 843
jaw diseases - chemically induced (843) 843
dentistry (708) 708
bone density conservation agents - adverse effects (689) 689
female (684) 684
male (613) 613
biological and medical sciences (560) 560
medical sciences (546) 546
dentistry, oral surgery & medicine (525) 525
middle aged (451) 451
otorhinolaryngology. stomatology (413) 413
aged (402) 402
facial bones, jaws, teeth, parodontium: diseases, semeiology (315) 315
risk factors (301) 301
non tumoral diseases (288) 288
bones (285) 285
adult (272) 272
necrosis (269) 269
animals (244) 244
bisphosphonates (242) 242
surgery (230) 230
osteonecrosis (228) 228
diphosphonates - therapeutic use (205) 205
pharmacology. drug treatments (199) 199
diphosphonates - administration & dosage (197) 197
jaw (188) 188
diseases of the osteoarticular system (187) 187
aged, 80 and over (179) 179
oncology (178) 178
bone density conservation agents - administration & dosage (173) 173
bone density conservation agent (170) 170
imidazoles - adverse effects (169) 169
osteoporosis - drug therapy (166) 166
osteoporosis (164) 164
abridged index medicus (161) 161
vascular bone diseases (159) 159
bone density conservation agents - therapeutic use (156) 156
bone neoplasms - drug therapy (146) 146
osteonecrosis - therapy (125) 125
osteonecrosis - pathology (122) 122
bone neoplasms - secondary (120) 120
diphosphonates (120) 120
care and treatment (118) 118
osteonecrosis - prevention & control (117) 117
jaw diseases - pathology (113) 113
jaw diseases - therapy (111) 111
jaw diseases - prevention & control (110) 110
multiple myeloma - drug therapy (107) 107
bones, joints and connective tissue. antiinflammatory agents (106) 106
retrospective studies (105) 105
treatment outcome (104) 104
administration, oral (103) 103
cancer (99) 99
rats (99) 99
time factors (98) 98
osteonecrosis - epidemiology (95) 95
bisphosphonate (94) 94
osteonecrosis of the jaw (94) 94
health aspects (92) 92
osteonecrosis - diagnosis (92) 92
phosphonates (90) 90
jaw diseases - epidemiology (87) 87
injections, intravenous (82) 82
antineoplastic agents - adverse effects (80) 80
drug therapy (80) 80
jaw diseases - diagnosis (80) 80
tumors (79) 79
breast neoplasms - drug therapy (75) 75
follow-up studies (75) 75
analysis (72) 72
general & internal medicine (72) 72
medicine, general & internal (72) 72
alendronate - adverse effects (71) 71
dose-response relationship, drug (71) 71
incidence (71) 71
osteonecrosis - surgery (70) 70
medicine & public health (69) 69
neoplasms - drug therapy (68) 68
mandibular diseases - chemically induced (66) 66
pharmacology & pharmacy (66) 66
research (64) 64
bisphosphonate-associated osteonecrosis of the jaw - etiology (62) 62
osteonecrosis - diagnostic imaging (62) 62
zoledronic acid (61) 61
disease models, animal (60) 60
jaw - drug effects (60) 60
tooth extraction - adverse effects (60) 60
denosumab (59) 59
endocrinology & metabolism (59) 59
jaw diseases - diagnostic imaging (59) 59
jaw diseases - surgery (59) 59
jaw - pathology (57) 57
rats, sprague-dawley (57) 57
complications and side effects (55) 55
multiple myeloma (55) 55
metastasis (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1448) 1448
French (24) 24
Japanese (21) 21
Spanish (18) 18
German (15) 15
Italian (10) 10
Portuguese (9) 9
Dutch (7) 7
Russian (4) 4
Norwegian (3) 3
Croatian (2) 2
Czech (2) 2
Danish (2) 2
Polish (2) 2
Swedish (2) 2
Chinese (1) 1
Hebrew (1) 1
Hungarian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Bisphosphonate-induced osteonecrosis of the jaw: A review of 2,400 patient cases
by Filleul, O and Crompot, E and Saussez, S
Journal of cancer research and clinical oncology, ISSN 0171-5216, 08/2010, Volume 136, Issue 8, pp. 1117 - 1124
Osteonecrosis of the jaws | Bisphosphonates | Epidemiology | Retrospective | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Vascular bone diseases | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Osteonecrosis - therapy | Humans | Male | Mandibular Diseases - surgery | Maxilla - surgery | Osteonecrosis - pathology | Maxillary Diseases - chemically induced | Bone Remodeling - drug effects | Osteitis Deformans - chemically induced | Sex Ratio | Jaw Diseases - chemically induced | Osteonecrosis - surgery | Maxillary Diseases - pathology | Jaw Diseases - pathology | Diphosphonates - therapeutic use | Maxillary Diseases - surgery | Female | Mandibular Diseases - chemically induced | Mandibular Diseases - pathology | Retrospective Studies | Osteonecrosis - chemically induced | Maxilla - pathology | Diphosphonates - adverse effects | Osteoporosis | Pharmacy | Phosphonates | Mars (Planet) | Bones | Universities and colleges | Metastasis | Health aspects | Necrosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long-Term Use of Bisphosphonates in Osteoporosis
by Watts, Nelson B and Diab, Dima L
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 04/2010, Volume 95, Issue 4, pp. 1555 - 1565
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Atrial Fibrillation - chemically induced | Bone Density Conservation Agents - pharmacokinetics | Esophageal Neoplasms - chemically induced | Bone Density Conservation Agents - adverse effects | Humans | Bone Density Conservation Agents - therapeutic use | Diphosphonates - pharmacokinetics | Osteoporosis - drug therapy | Clinical Trials as Topic | Long-Term Care | Pain - chemically induced | Bone Density Conservation Agents - pharmacology | Jaw Diseases - chemically induced | Fractures, Bone - etiology | Osteoporosis - complications | Kidney Diseases - chemically induced | Diphosphonates - therapeutic use | Osteonecrosis - chemically induced | Diphosphonates - adverse effects | Diphosphonates - pharmacology | Fractures, Bone - prevention & control | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Side effects of drugs on the oral cavity
by Bascones-Martínez, Antonio and Muñoz-Corcuera, Marta and Bascones-Ilundain, Cristina
Medicina clínica, ISSN 0025-7753, 02/2015, Volume 144, Issue 3, pp. 126 - 131
Drugs | Oral cavity | Adverse reaction | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Disease Susceptibility | Tongue Diseases - chemically induced | Vasoconstrictor Agents - adverse effects | Halitosis - chemically induced | Humans | Pigmentation Disorders - chemically induced | Sialometaplasia, Necrotizing - chemically induced | Gingival Diseases - chemically induced | Hemorrhagic Disorders - chemically induced | Stomatitis - etiology | Opportunistic Infections - etiology | Mouth Diseases - chemically induced | Stomatitis - chemically induced | Immunosuppressive Agents - adverse effects | Salivary Gland Diseases - chemically induced | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Taste Disorders - chemically induced | Mouth Diseases - pathology | Xerostomia - chemically induced
Journal Article
Details down arrow
4. Full Text Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment
by Marx, Robert E and Sawatari, Yoh and Fortin, Michel and Broumand, Vishtasb
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 2005, Volume 63, Issue 11, pp. 1567 - 1575
Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Vascular bone diseases | Medical sciences | Jaw Diseases - diagnosis | Humans | Jaw Diseases - therapy | Bone Neoplasms - secondary | Dexamethasone - adverse effects | Male | Osteoporosis - drug therapy | Antineoplastic Agents - therapeutic use | Abscess - complications | Osteopetrosis - chemically induced | Tooth Extraction - adverse effects | Jaw Diseases - chemically induced | Multiple Myeloma - drug therapy | Drug Interactions | Antineoplastic Agents - adverse effects | Dental Caries - complications | Diphosphonates - therapeutic use | Abscess - therapy | Female | Bone Neoplasms - drug therapy | Diphosphonates - adverse effects | Prostatic Neoplasms - drug therapy | Hyperostosis - therapy | Osteonecrosis - diagnosis | Prostatic Neoplasms - pathology | Osteonecrosis - therapy | Bone Density Conservation Agents - adverse effects | Dental Caries - therapy | Multiple Myeloma - complications | Imidazoles - adverse effects | Risk Factors | Periodontitis - therapy | Bone Density Conservation Agents - therapeutic use | Osteopetrosis - therapy | Bone Neoplasms - complications | Breast Neoplasms - drug therapy | Hyperostosis - complications | Breast Neoplasms - complications | Alendronate - adverse effects | Dexamethasone - therapeutic use | Breast Neoplasms - pathology | Osteopetrosis - diagnosis | Periodontitis - complications | Prostatic Neoplasms - complications | Osteonecrosis - chemically induced | Surgery, Plastic | Diphosphonates | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients
by Sonis, Stephen T and Watkins, Brynmor A and Lyng, Gregory D and Lerman, Mark A and Anderson, Kenneth C
Oral oncology, ISSN 1368-8375, 2008, Volume 45, Issue 2, pp. 164 - 172
Otolaryngology | Hematology, Oncology and Palliative Medicine | Jaw | Animal model | Osteonecrosis | Bisphosphonates | Dental extractions | Oncology | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Tumors | Injections, Intravenous | Prospective Studies | Imidazoles - administration & dosage | Dexamethasone - adverse effects | Osteonecrosis - pathology | Oral Ulcer - chemically induced | Bone Diseases, Metabolic - drug therapy | Jaw Diseases - chemically induced | Maxillary Diseases - pathology | Jaw Diseases - pathology | Female | Mandibular Diseases - chemically induced | Diphosphonates - adverse effects | Disease Models, Animal | Dexamethasone - administration & dosage | Bone Density Conservation Agents - adverse effects | Imidazoles - adverse effects | Rats | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Maxillary Diseases - chemically induced | Rats, Sprague-Dawley | Animals | Mandibular Diseases - pathology | Oral Ulcer - pathology | Osteonecrosis - chemically induced | Apoptosis | Medical colleges | Care and treatment | Cancer patients | Dexamethasone | Diphosphonates | Multiple myeloma | Bones | Necrosis | Cancer | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment
by Marx, Robert E., DDS and Cillo, Joseph E., DDS and Ulloa, Juan J., DDS
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 2007, Volume 65, Issue 12, pp. 2397 - 2410
Surgery | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Vascular bone diseases | Medical sciences | Collagen Type I - blood | Peptides - blood | Osteonecrosis - therapy | Prospective Studies | Bone Density Conservation Agents - adverse effects | Humans | Middle Aged | Jaw Diseases - therapy | Biomarkers - blood | Osteonecrosis - blood | Jaw Diseases - chemically induced | Alendronate - adverse effects | Time Factors | Etidronic Acid - adverse effects | Female | Jaw Diseases - blood | Osteonecrosis - chemically induced | Risedronate Sodium | Diphosphonates - adverse effects | Etidronic Acid - analogs & derivatives | Prevention | Bones | Necrosis | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Resolution of Oral Bisphosphonate and Steroid-Related Osteonecrosis of the Jaw—A Serial Case Analysis
by Chiu, Chang-Ta, DDS, MS and Chiang, Wei-Fan, DDS, MS and Chuang, Ching-Ya, DDS and Chang, Sung-Wen, DDS, MS
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 2010, Volume 68, Issue 5, pp. 1055 - 1063
Surgery | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Otorhinolaryngology. Stomatology | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Vascular bone diseases | Medical sciences | Glucocorticoids - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Jaw Diseases - therapy | Osteolysis - chemically induced | Mandibular Diseases - therapy | Jaw Diseases - chemically induced | Anti-Bacterial Agents - therapeutic use | Jaw Diseases - microbiology | Aged, 80 and over | Mandibular Diseases - chemically induced | Maxillary Diseases - therapy | Osteosclerosis - therapy | Diphosphonates - adverse effects | Glucocorticoids - adverse effects | Osteonecrosis - therapy | Bone Density Conservation Agents - adverse effects | Administration, Oral | Risk Factors | Treatment Outcome | Diphosphonates - administration & dosage | Jaw Diseases - classification | Bone Density Conservation Agents - administration & dosage | Maxillary Diseases - chemically induced | Debridement | Alendronate - adverse effects | Osteolysis - therapy | Actinomycosis - complications | Osteonecrosis - classification | Taiwan | Aged | Osteonecrosis - chemically induced | Osteonecrosis - microbiology | Hyperbaric Oxygenation | Osteosclerosis - chemically induced | Alendronate - administration & dosage | Bones | College teachers | Universities and colleges | Necrosis | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome
by Yarom, N and Yahalom, R and Shoshani, Y and Hamed, W and Regev, E and Elad, S
Osteoporosis international, ISSN 0937-941X, 10/2007, Volume 18, Issue 10, pp. 1363 - 1370
Jaws | Osteomyelitis | Osteoporosis | Bisphosphonate | Medicine & Public Health | Alendronate | Gynecology | Orthopedics | Rheumatology | Osteonecrosis | Endocrinology | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Biological and medical sciences | Vascular bone diseases | Medical sciences | Bacterial arthritis and osteitis | Smoking - adverse effects | Jaw Diseases - diagnosis | Osteonecrosis - diagnosis | Bone Density Conservation Agents - adverse effects | Humans | Middle Aged | Dental Care - adverse effects | Diphosphonates - metabolism | Osteoporosis - drug therapy | Treatment Outcome | Jaw Diseases - chemically induced | Osteonecrosis - drug therapy | Female | Aged | Quality of Life - psychology | Retrospective Studies | Osteonecrosis - chemically induced | Bone Density Conservation Agents - metabolism | Diphosphonates - adverse effects | Jaw Diseases - drug therapy | Head | Side effects | Drug therapy | Mouth | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Oral Complications Associated With D‐Penicillamine Treatment for Wilson Disease: A Clinicopathologic Report
by Tovaru, Serban and Parlatescu, Ioannina and Dumitriu, Anca‐Silvia and Bucur, Alexandru and Kaplan, Ilana
Journal of periodontology (1970), ISSN 0022-3492, 08/2010, Volume 81, Issue 8, pp. 1231 - 1236
penicillamine | case report | Adverse effects | elastin | hepatolenticular degeneration | periodontitis | Case report | Hepatolenticular degeneration | Penicillamine | Periodontitis | Elastin | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Otorhinolaryngology. Stomatology | Non tumoral diseases | Other metabolic disorders | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Biological and medical sciences | Metabolic diseases | Medical sciences | Facial bones, jaws, teeth, parodontium: diseases, semeiology | Metals (hemochromatosis...) | Elastic Tissue - drug effects | Follow-Up Studies | Tongue Diseases - chemically induced | Humans | Middle Aged | Cheilitis - chemically induced | Candidiasis, Oral - etiology | Periodontal Pocket - chemically induced | Gingival Hemorrhage - chemically induced | Periodontitis - chemically induced | Penicillamine - adverse effects | Trientine - therapeutic use | Gingival Recession - chemically induced | Mouth Diseases - chemically induced | Adult | Female | Hepatolenticular Degeneration - drug therapy | Tongue Diseases - microbiology | Gingival Hyperplasia - chemically induced | Granuloma - chemically induced | Lip Diseases - etiology | Chelating Agents - adverse effects | Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Nationwide Survey for Bisphosphonate-Related Osteonecrosis of the Jaws in Japan
by Urade, Masahiro, DDS, PhD and Tanaka, Noriaki, DDS, PhD and Furusawa, Kiyofumi, DDS, PhD and Shimada, Jun, DDS, PhD and Shibata, Takanori, DDS, PhD and Kirita, Tadaaki, DDS, PhD and Yamamoto, Tetsuya, DDS, PhD and Ikebe, Tetsuro, DDS, PhD and Kitagawa, Yoshimasa, DDS, PhD and Fukuta, Jinichi, DDS, PhD
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 2011, Volume 69, Issue 11, pp. e364 - e371
Surgery | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Japan - epidemiology | Injections, Intravenous | Follow-Up Studies | Osteonecrosis - epidemiology | Humans | Middle Aged | Jaw Diseases - therapy | Male | Antineoplastic Agents - therapeutic use | Mandibular Diseases - therapy | Jaw Diseases - chemically induced | Time Factors | Osteotomy - statistics & numerical data | Aged, 80 and over | Adult | Female | Mandibular Diseases - chemically induced | Maxillary Diseases - therapy | Retrospective Studies | Diphosphonates - adverse effects | Osteonecrosis - therapy | Bone Density Conservation Agents - adverse effects | Administration, Oral | Risk Factors | Maxillary Diseases - epidemiology | Neoplasms - mortality | Treatment Outcome | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Jaw Diseases - epidemiology | Maxillary Diseases - chemically induced | Disease Progression | Oral Hygiene | Mandibular Diseases - epidemiology | Tooth Extraction - statistics & numerical data | Aged | Osteonecrosis - chemically induced | Cohort Studies | Surveys | Medical colleges | Surgery, Plastic | Medical societies | Surgeons | Bones | College teachers | Necrosis | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
by Ruggiero, Salvatore L., DMD, MD and Dodson, Thomas B., DMD, MPH and Fantasia, John, DDS and Goodday, Reginald, DDS, MSc and Aghaloo, Tara, DDS, MD, PhD and Mehrotra, Bhoomi, MD and O'Ryan, Felice, DDS and American Association of Oral and Maxillofacial Surgeons
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 2014, Volume 72, Issue 10, pp. 1938 - 1956
Surgery | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Jaw Diseases - diagnosis | Neovascularization, Physiologic - drug effects | Humans | Jaw Diseases - therapy | Osteoporosis - drug therapy | Bone Remodeling - drug effects | Oral Surgical Procedures - adverse effects | Jaw Diseases - chemically induced | Patient Care Planning | Time Factors | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - adverse effects | Osteonecrosis - diagnosis | Diagnosis, Differential | Osteonecrosis - therapy | Bone Density Conservation Agents - adverse effects | Risk Assessment | Risk Factors | Terminology as Topic | Neoplasms - drug therapy | Bone Resorption - prevention & control | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Osteonecrosis - chemically induced | Medical colleges | Strategic planning (Business) | Surgeons | Bones | College teachers | Trade and professional associations | Necrosis | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights